← back to search

Haibo Zhang

Guangzhou University of Chinese Medicine · CN
Area of research
Pulmonary and Respiratory Medicine · Immunology
Research interest
Research interests include Respiratory Support and Mechanisms, Neonatal Respiratory Health Research, Immune Response and Inflammation, and Sepsis Diagnosis and Treatment.
h-index
59
citations
15,827
works
243
NIH funding
primary concept
Medicine
email

Recent publications

Methods and applications of patient-derived organoid models for immune microenvironment and immunotherapy research in multiple cancer types
Experimental Hematology and Oncology 2026cited by 0position: lastdoi
CD44/POU2F2/BCL9L axis mediates MIF-driven SPP1 <sup>+</sup> TAM activation in colorectal cancer metastasis
International Journal of Biological Sciences 2026cited by 0position: middledoi
An exploratory serum metabolomics study for screening and staging of breast cancer
Gynecological Endocrinology 2026cited by 0position: lastdoi
Targeting the Secretin Receptor in Macrophages Attenuates Silica‐Induced Pulmonary Fibrosis
Cell Proliferation 2025cited by 3position: middledoi
Durable response to Olaparib in EGFR and somatic BRCA2-mutated lung adenocarcinoma with leptomeningeal metastases: a case report
Frontiers in Oncology 2025cited by 2position: lastdoi
Pharmacological therapies and drug development targeting SARS-CoV-2 infection
Cytokine & Growth Factor Reviews 2022cited by 14position: middledoi
Genome-wide spatial expression profiling in formalin-fixed tissues
Cell Genomics 2021cited by 116position: middledoi
Association between use of Qingfei Paidu Tang and mortality in hospitalized patients with COVID-19: A national retrospective registry study
Phytomedicine 2021cited by 68position: middledoi
MicroRNA-200b-3p promotes endothelial cell apoptosis by targeting HDAC4 in atherosclerosis
BMC Cardiovascular Disorders 2021cited by 59position: middledoi
Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
Intensive Care Medicine 2020cited by 2,816position: firstdoi
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
Cell 2020cited by 2,259position: middledoi
Human recombinant soluble ACE2 in severe COVID-19
The Lancet Respiratory Medicine 2020cited by 428position: middledoi
JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality
Science Advances 2020cited by 216position: middledoi
Human soluble ACE2 improves the effect of remdesivir in SARS‐CoV‐2 infection
EMBO Molecular Medicine 2020cited by 106position: middledoi
Protective function of DJ-1/PARK7 in lipopolysaccharide and ventilator-induced acute lung injury
Redox Biology 2020cited by 83position: middledoi
&lt;p&gt;Modulation of Human Neutrophil Peptides on &lt;em&gt;P. aeruginosa&lt;/em&gt; Killing, Epithelial Cell Inflammation and Mesenchymal Stromal Cell Secretome Profiles&lt;/p&gt;
Journal of Inflammation Research 2019cited by 2position: lastdoi
Dual effects of human neutrophil peptides in a mouse model of pneumonia and ventilator-induced lung injury
Respiratory Research 2018cited by 18position: lastdoi
T regulatory cells and dendritic cells protect against transfusion-related acute lung injury via IL-10
Blood 2017cited by 117position: middledoi
Role of Transient Receptor Potential Vanilloid 4 in Neutrophil Activation and Acute Lung Injury
American Journal of Respiratory Cell and Molecular Biology 2015cited by 130position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Arthur S. Slutsky · Toronto Rehabilitation Institute5 papers (2017–2020)Josef Penninger · Helmholtz Centre for Infection Research5 papers (2020–2021)Alì Mirazimi · Public Health Agency of Sweden4 papers (2020–2021)Núria Montserrat · Institució Catalana de Recerca i Estudis Avançats4 papers (2020–2021)Yimin Li · St. Michael's Hospital3 papers (2018–2020)Vanessa Monteil · Public Health Agency of Sweden3 papers (2020–2021)Wolfgang M. Kuebler · University of Toronto3 papers (2015–2020)Nanshan Zhong · Creighton University2 papers (2018–2020)Arata Tabuchi · Charité - Universitätsmedizin Berlin2 papers (2015–2017)Alice Luo · Guangzhou Medical University2 papers (2017–2018)Gerald Wirnsberger · Medical University of Graz2 papers (2020–2020)Julie Khang · Guangzhou Medical University2 papers (2018–2019)Kaijiang Yu · Brigham and Women's Hospital2 papers (2018–2019)Yongbo Huang · First Affiliated Hospital of Guangzhou Medical University2 papers (2018–2019)Diana Islam · Hospital for Sick Children2 papers (2018–2019)Carmen Hurtado del Pozo · Breakthrough2 papers (2020–2020)Hyesoo Kwon · Karolinska University Hospital2 papers (2020–2020)Jun Yin · University of Electronic Science and Technology of China2 papers (2015–2020)Junbo Zheng · Harbin Medical University1 papers (2018–2018)Jonathan Liu · University of Washington1 papers (2017–2017)